Please login to the form below

Not currently logged in
Email:
Password:

Takeda UK adds to its senior leadership team

Simon Meadowcroft and Pauline Bromley join the firm 

Takeda UKTakeda UK has added new names to its senior team with the appointment of a new medical director and human resources director.

Simon Meadowcroft joins as medical director, having held senior positions at Novartis and GSK, working with stakeholders to develop and drive strategy for key assets in their oncology portfolios.

Pauline Bromley also takes up the new position of human resources director and has over 15 years of experience working with small and large pharmaceutical organisations. She joins from LEO Pharma where she established professional and commercial HR practices to support a culture encouraging improved performance.

Adam Zaeske, managing director of Takeda UK, said: “We are working within a constantly changing healthcare environment and the medical function under the medical director's leadership will be crucial to ensure we align and work in partnership with the NHS as we bring important new medicines to market.

“Takeda is committed to advancing healthcare by developing specialist medicines that meet the needs of patients, healthcare professionals and society. Our focus on that goal means we need to ensure that our employees have the right skills and experience and are truly inspired to make a real difference.

“The recruitment of these two new senior roles will ensure that we are perfectly positioned to deliver on our aspirations.”

19th November 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics